Angiodynamics Inc (ANGO) 13.57 $ANGO PAVmed Inc.

New Post Public Reply Private Reply Replies (0) Message Board

Jun 23, 2016 at 3:25 AM

Angiodynamics Inc (ANGO) 13.57 $ANGO

PAVmed Inc. (Nasdaq: PAVMU) to Ring The Nasdaq Stock Market Opening Bell
GlobeNewswire - Thu Apr 28, 11:09AM CDT
What:
PAVMU: 13.00 (+1.75), ANGO: 13.57 (-0.14), NDAQ: 63.09 (+0.12)

AngioDynamics Tops Q3 Earnings, Sales; FY16 View Pruned
Zacks Equity Research - Zacks Investment Research - Fri Apr 08, 9:00AM CDT
AngioDynamics Inc. (ANGO) reported adjusted earnings of 15 cents per share in the third quarter of fiscal 2016, which beat the Zacks Consensus Estimate by a couple cents.
LMAT: 14.69 (+0.15), AMAG: 24.46 (+0.83), ANGO: 13.57 (-0.14), OFIX: 44.33 (-0.42)

Natus Medical: A Strong Sell on Weak Q1 & Estimate Revision
Zacks Equity Research - Zacks Investment Research - Thu Apr 07, 12:00PM CDT
On Apr 7, Zacks Investment Research downgraded Natus Medical Inc (BABY) to a Zacks Rank #5 (Strong Sell).
BABY: 35.66 (+0.45), GMED: 23.24 (+0.06), ARAY: 5.13 (+0.05), ANGO: 13.57 (-0.14)

Mazor Robotics Receives 5 Orders in Q1, Shares Down
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 12:20PM CDT
Shares of Mazor Robotics Ltd. (MZOR) fell 4.1% to close at $11.60 on Apr 5, after the company announced the receipt of five orders for Renaissance system.
GMED: 23.24 (+0.06), MZOR: 17.65 (-0.63), ARAY: 5.13 (+0.05), ANGO: 13.57 (-0.14)

Downgrade Alert for Angiodynamics (ANGO)
Comtex SmarTrend(R) - Wed Apr 06, 3:16AM CDT
Angiodynamics (NASDAQ:ANGO) was downgraded from Buy to Hold at Canaccord Genuity today. The stock closed yesterday at $11.07 on volume of 222,000 shares, above average daily volume of 75,000. AngioDynamics, Inc. designs, develops, manufactures, and markets therapeutic and diagnostic devices. The Company's products enable interventional physicians to treat peripheral vascular disease and other non-coronary diseases. AngioDynamic's product lines consist of angiographic catheters, hemodialysis catheters, image guided vascular access products, and thrombolytic products.
ANGO: 13.57 (-0.14)

Can the Uptrend Continue for AngioDynamics (ANGO)?
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 8:49AM CDT
Investors certainly have to be happy with AngioDynamics, Inc. (ANGO) and its short term performance
ANGO: 13.57 (-0.14)

AngioDynamics Appoints James C. Clemmer as New President and Chief Executive Officer
GlobeNewswire - Mon Apr 04, 7:00AM CDT
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the appointment of James C. Clemmer as the company's new President and Chief Executive Officer, effective April 4, 2016.
ANGO: 13.57 (-0.14)

AngioDynamics to Report Fiscal 2016 Third Quarter Financial Results
GlobeNewswire - Tue Mar 29, 5:30AM CDT
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 third quarter ended February 29, 2016, on Thursday, April 7, 2016, after the close of the U.S. financial markets.
ANGO: 13.57 (-0.14)

Inogen (INGN) Q4 Earnings: A Surprise in the Cards?
Zacks Equity Research - Zacks Investment Research - Fri Mar 11, 9:50AM CST
Inogen Inc. (INGN) is scheduled to report fourth-quarter 2015 earnings on Mar 14.
EW: 98.04 (-0.53), INGN: 44.89 (-0.86), LMNX: 19.69 (-0.03), ANGO: 13.57 (-0.14)

AngioDynamics and Merz North America Establish Multi-Year Relationship to Market Asclera for Vein Patients
GlobeNewswire - Thu Mar 10, 5:30AM CST
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that they have signed an agreement with Merz North America, U.S. affiliate of the global Merz Pharma Group, to serve as the exclusive distributor of Asclera(R) (polidocanol) Injection within the vein market in the U.S.
ANGO: 13.57 (-0.14)

AngioDynamics to Present at the Barclays Global Healthcare Conference
GlobeNewswire - Mon Mar 07, 5:30AM CST
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo, President and Chief Executive Officer, is scheduled to participate in a Q&A session at the Barclays Global Healthcare Conference on Thursday, March 17, 2016, at 8:00 a.m. ET. The conference will be held at the Loews Miami Beach Hotel in Miami, FL.
ANGO: 13.57 (-0.14)

AngioDynamics: Health Canada Okays Celerity with Navigation
Zacks Equity Research - Zacks Investment Research - Tue Feb 09, 3:20PM CST
AngioDynamics (ANGO) recently announced that Health Canada has approved the company's Celerity PICC Tip Confirmation System with Navigation.
ABMD: 101.70 (-0.06), EXAC: 26.12 (-0.63), LMNX: 19.69 (-0.03), ANGO: 13.57 (-0.14)

Mauna Kea Technologies Announces the Appointment of Joseph DeVivo as a Non-Executive Director
PR Newswire - Mon Jan 11, 11:00AM CST
Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced the appointment of Joseph M. DeVivo as a Director. Mr. DeVivo is the President and Chief Executive Officer of AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology.
ANGO: 13.57 (-0.14)

AngioDynamics Q2 Earnings In Line, Sales Top; '16 View Cut
Zacks Equity Research - Zacks Investment Research - Fri Jan 08, 8:20AM CST
AngioDynamics (ANGO) reported adjusted earnings of 14 cents per share in the second quarter of fiscal 2016, which were in line with the Zacks Consensus Estimate but down 17.6% on a year-over-year basis.
CAPR: 4.27 (-0.05), NXTM: 19.38 (-0.54), ABAX: 45.30 (-0.68), ANGO: 13.57 (-0.14)

AngioDynamics Reports Fiscal 2016 Second Quarter Results
GlobeNewswire - Thu Jan 07, 3:01PM CST
-- Net sales of $89.2 million
ANGO: 13.57 (-0.14)

AngioDynamics to Present at the 34th Annual J.P. Morgan Global Healthcare Conference
GlobeNewswire - Mon Jan 04, 5:30AM CST
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph DeVivo, President and Chief Executive Officer, is scheduled to present at the 34 Annual J.P. Morgan Global Healthcare Conference on Wednesday, January 13, 2016, at 5:30 p.m. EST. The conference will be held at the Westin St. Francis in San Francisco, Ca.
JPM: 62.71 (-0.24), ANGO: 13.57 (-0.14)

AngioDynamics to Report Fiscal 2016 Second Quarter Financial Results
GlobeNewswire - Mon Dec 28, 5:30AM CST
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 second quarter ended November 30, 2015, on Thursday, January 7, 2016, after the close of the U.S. financial markets.
ANGO: 13.57 (-0.14)

A Change in Tides - Analyst Notes on Hemisphere Media Group, AngioDynamics, ChemoCentryx and Catalyst Pharmaceuticals
ACCESSWIRE - Thu Dec 17, 6:55AM CST
NEW YORK, NY / ACCESSWIRE / December 17, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Hemisphere Media Group Inc. (NASDAQ: HMTV), AngioDynamics Inc. (NASDAQ: ANGO), ChemoCentryx Inc. (NASDAQ: CCXI) and Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
CPRX: 0.89 (+0.04), HMTV: 11.05 (-0.14), CCXI: 4.43 (-0.05), ANGO: 13.57 (-0.14)

Angiodynamics Shares Down 33.0% Since SmarTrend's Sell Call (ANGO)
Comtex SmarTrend(R) - Tue Dec 15, 10:07AM CST
SmarTrend identified a Downtrend for Angiodynamics (NASDAQ:ANGO) on March 6th, 2015 at $18.05. In approximately 9 months, Angiodynamics has returned 32.96% as of today's recent price of $12.10.
ANGO: 13.57 (-0.14)

33.0% Return Seen to Date on SmarTrend Angiodynamics Call (ANGO)
Comtex SmarTrend(R) - Tue Dec 15, 10:00AM CST
SmarTrend identified a Downtrend for Angiodynamics (NASDAQ:ANGO) on March 6th, 2015 at $18.05. In approximately 9 months, Angiodynamics has returned 32.96% as of today's recent price of $12.10.
ANGO: 13.57 (-0.14)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Africa-Caribbean Trade Potential: A $1.65B Opportunity

Untapped Opportunities Between Africa and the Caribbean Who's ready to shake up the trade game between Africa and the Caribbean? According to a fresh-off-the-press report from the International Trade Centre (ITC) and Afreximbank, we could be looking at a whopping $1.65 billion in annual trade between these two regions by 2030. That's right, a billion with a 'B'. But let...

Speakeasy Dispensary Brings Medical Cannabis to Maysville

New Chapter for Maysville: Speakeasy Opens Doors Normally, you'd think of medical cannabis expansions as dry numbers and policies, but with Speakeasy Dispensary making its mark in Maysville, it's not just about business; it's a service to the community. Nestled into 317 W 2nd St, this is more than a simple retail spot. It's about bringing medical options straight to the...

Camect and 3Si Partnership: Revolutionizing Public Safety

Smarter Surveillance with Camect and 3Si A fresh collaboration is stirring the security pot, straight from Silicon Valley's buzzing tech nest. Camect, the brainiacs behind AI-powered video smarts, are shaking hands with 3Si Security Systems. In plain talk, they're hooking up Camect's sharp-eyed video tech with 3Si's DirectToDispatch™ system. This ain’t some techie...

Meteor Education Bolsters CTE Reach with AET Labs Buy

Meteor's Move: AET Labs Picked Up in CTE Plays You see, Meteor Education ain't sitting on its hands, that's for sure. They're out here hoarding strategic pieces like it's a chess match, snatching up AET Labs to bolster their already sturdy CTE playbook. No financial details spilled, but hell, that’s par for the course. This move plants them even more firmly in New...

Massimo Debuts 1500 UTV Line at 2026 SEMA Show

Setting the Stage at SEMA 2026 In the chaotic whirl of the 2026 SEMA Show, Massimo Group didn't just roll out new wheels—they took a leap into the big leagues. Amidst the bustling Vegas crowd, Massimo unveiled their latest babies: the Warrior 1500XD and the Sentinel 1500 HVAC Crew. These ain't just any UTVs; they're packing some serious muscle with a 1,499cc engine,...

Lupin Launches HIV Treatment, Secures 180-Day Exclusivity

Lupin's Market Move: A Big Step in HIV Treatment There's a fresh gust blowing in the pharmaceutical skies today, as Lupin leaps ahead with the launch of their Raltegravir Tablets in the U.S. The company just bagged FDA approval, putting them on the front lines with a high-stake 180-day exclusivity period for their generic version. For investors keeping tabs on pharma...

Reju Partners with Six Mills to Advance Textile Regeneration

Big Moves in Textile Regeneration Now here's a move that's got the fabric world buzzing: Reju, the scrappy textile-to-textile regenerative powerhouse, is teaming up with six mills spread across Europe and the U.S. They’re setting the stage to crank up their polyester recycling game and flood the market with sustainable, eco-friendly fabrics. It's a bold step toward...

TETRA Hits High Mark with Robust Q3 Earnings Surge

Financial Milestones and Market Insights Boy, if you're not watching TETRA Technologies (NYSE:TTI) right now, you're probably missing out on a real barnstormer of a financial report. The numbers are looking chalkboards-be-damned stellar! They’ve just notched their finest third quarter in a decade, bringing in revenues through the roof at $168 million—an impressive 10%...

Windward Expands Maritime Scope with Azimut.ai Deal

An Invincible Maritime Shield When it comes to maritime intelligence, Windward just pulled a fast one. In a market where staying ahead of the game is like playing three-dimensional chess, they've snatched up Azimut.ai. This ain't some small fry; it's a visual intelligence firm poised to shore up Windward's grip on the elusive maritime world. Charting New Waters with...

Renue Hawaii Ups Carpet Cleaning Game for Holidays

The Stakes of Carpet Care in Hawaii's Resorts Ah, Hawaii—the land of breathtaking beaches, vibrant luaus, and plush hotel carpets that take a beating every peak travel season. But before you brush off carpet care as mundane as a hollow coconut, let’s talk serious business. Renue Hawaii isn't fooling around with some one-size-fits-all cleaning routine. They’ve just...